1. ALLA AKTIER
  2. NYHETER
  3. VÄSTRA HAMNEN CORP. FINANCE

Västra Hamnen Corp. Finance

Nyheter Västra Hamnen Corp. Finance Nyheter alla bolag

Gabather: TOTEMS-study delayed, not derailed

  • Issues with clinical test material delays TOTEMS-study
  • New chairman elected at the AGM
  • We keep our fair value of SEK 0.092 per share

Before releasing its Q2 2025 report, Gabather announced that the TOTEMS-study would be delayed due to issues with the clinical trial material. Meanwhile, changes have taken place in the company’s board, with a new chairman being elected. Despite challenges, we maintain our fair value of SEK 0,092 per share.

The full report is available here.

About Market Focus

The research report is prepared as part of Market Focus, Västra Hamnen Corporate Finance's commissioned research offering.

This is a press release from Västra Hamnen Corporate Finance AB. 
Web: vhcorp.se
Twitter: @vhcorp_se (https://x.com/vhcorp_se)

Datum 2025-09-01, kl 12:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!